141 related articles for article (PubMed ID: 18274835)
1. Personalized systemic treatment for breast cancer patients: is it a reality?
Shimizu C; Fujiwara Y
Breast Cancer; 2008; 15(2):141-4. PubMed ID: 18274835
[TBL] [Abstract][Full Text] [Related]
2. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
Nagasaki K; Miki Y
Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
[TBL] [Abstract][Full Text] [Related]
3. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
4. Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
Cosler LE; Lyman GH
Cancer Invest; 2009 Dec; 27(10):953-9. PubMed ID: 19909009
[No Abstract] [Full Text] [Related]
5. Gene expression-based diagnosis of efficacy of chemotherapy for breast cancer.
Miki Y
Breast Cancer; 2010 Apr; 17(2):97-102. PubMed ID: 20013078
[TBL] [Abstract][Full Text] [Related]
6. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
7. New generation of molecular prognostic and predictive tests for breast cancer.
Pusztai L; Cristofanilli M; Paik S
Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of breast cancer: toward the individualization of therapy.
Chang JC; Hilsenbeck SG; Fuqua SA
Cancer Invest; 2009 Aug; 27(7):699-703. PubMed ID: 19637041
[No Abstract] [Full Text] [Related]
9. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy and pharmacogenomic programs.
Iqbal S; Lenz HJ
Cancer; 2003 Apr; 97(8 Suppl):2076-82. PubMed ID: 12673699
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A
Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644
[TBL] [Abstract][Full Text] [Related]
12. Predictive markers of response to neoadjuvant chemotherapy in breast cancer.
Tewari M; Krishnamurthy A; Shukla HS
Surg Oncol; 2008 Dec; 17(4):301-11. PubMed ID: 18467090
[TBL] [Abstract][Full Text] [Related]
13. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
14. Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible?
Pusztai L; Rouzier R; Wagner P; Symmans WF
Drug Resist Updat; 2004 Dec; 7(6):325-31. PubMed ID: 15790543
[TBL] [Abstract][Full Text] [Related]
15. Predicting responses to chemotherapy in breast cancer: from bench to bedside.
Akashi-Tanaka S
Breast Cancer; 2010 Apr; 17(2):92-6. PubMed ID: 19789951
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling: decoding breast cancer.
de Snoo F; Bender R; Glas A; Rutgers E
Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic and predictive impact of protein expression profiling in high risk breast cancer patients treated with high-dose chemotherapy].
Diallo-Danebrock R; Ting E; Gluz O; Herr A; Mohrmann S; Geddert H; Gabbert HE; Nitz U; Poremba C
Verh Dtsch Ges Pathol; 2007; 91():187-96. PubMed ID: 18314614
[TBL] [Abstract][Full Text] [Related]
18. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
[TBL] [Abstract][Full Text] [Related]
19. NCI launches an innovative design for a breast cancer clinical trial.
Whitworth A
J Natl Cancer Inst; 2006 Sep; 98(17):1178-9. PubMed ID: 16954467
[No Abstract] [Full Text] [Related]
20. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
